The Tau hypothesis emphasizes that the principle causative substance of AD is Tau62, and previous studies have revealed that Tau pathology, as measured by positron-emission tomography (PET) imaging, is closely associated with AD progression63. The gene discussed is MAPT; the disease is Alzheimer disease.